Inappropriate use of antiarrhythmic drugs in paroxysmal and persistent atrial fibrillation in a large contemporary international survey: Insights from RealiseAF

Europace

Volumn 15, Issue 12, 2013, Pages 1733-1740

  Chiang, Chern En ^a   Goethals, Marnix ^b   O'Neill, James O ^c   Naditch Brûlé, Lisa ^b   Brette, Sandrine ^b   Gamra, Habib ^d   Zharinov, Oleg ^e   Steg, P Gabriel ^f,g,h  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b H Hartziekenhuis Roeselare Menen ^*

^c ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^d FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

^e SHUPYK NATIONAL MEDICAL ACADEMY OF POSTGRADUATE EDUCATION   (Ukraine)

^f INSERM   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

^h BICHAT HOSPITAL   (France)

Author keywords

Antiarrhythmic drugs; Atrial fibrillation; Guidelines

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; CARDIAC GLYCOSIDE; FLECAINIDE; PROPAFENONE; SOTALOL;

ADULT; AGED; ARTICLE; CARDIOLOGIST; DRUG USE; ELECTROCARDIOGRAM; FEMALE; HEALTH CARE SURVEY; HEART ATRIUM FIBRILLATION; HOLTER MONITORING; HUMAN; INTERNIST; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; PAROXYSMAL HEART ATRIUM FIBRILLATION; PERSISTENT HEART ATRIUM FIBRILLATION; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; TREATMENT INDICATION;

ANTIARRHYTHMIC DRUGS; ATRIAL FIBRILLATION; GUIDELINES;

AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION REVIEW; ELECTROCARDIOGRAPHY; FEMALE; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HUMANS; INAPPROPRIATE PRESCRIBING; MALE; MIDDLE AGED; PATIENT SELECTION; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84890460814     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut204     Document Type: Article

References (19)

1. Kirchhof P, Auricchio A, Bax J, Crijns H, Camm J, Diener HC et al. Outcome parameters for trials in atrial fibrillation: executive summary. Europace 2007;9: 1006-23.
2. Fuster V, Rydén LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary: a Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 2001;38:1231-65.
3. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al. ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006;8:651-745.
4. Nieuwlaat R, Capucci A, Camm AJ, Olsson SB, Andresen D, DaviesDWet al. Atrial fibrillation management: a prospective survey in ESC Member Countries. Eur Heart J 2005;26:2422-34.
5. Meiltz A, ZimmermannM, Urban P, Bloch A. Atrial fibrillation management by practice cardiologists: a prospective survey on the adherence to guidelines in the real world. Europace 2008;10:674-80.
6. Nabauer M, Gerth A, Limbourg T, Schneider S, Oeff M, Kirchhof P et al. The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management. Europace 2009;11:423-34.
7. Steg PG, Alam S, Chiang CE, Gamra H, Goethals M, Inoue H et al. Symptoms, functional status, and quality of life in patients with controlled and uncontrolled atrial fibrillation. Data from the RealiseAF cross-sectional international registry. Heart 2011; 98:195-201.
8. Lewis WR, Peterson ED, Cannon CP, Super DM, LaBresh KA, Quealy K et al. An organized approach to improvement in guideline adherence for acute myocardial infarction: results with the get with the guidelines quality improvement program. Arch Intern Med 2008;168:1813-9.
9. Mehta RH, RoeMT, Chen AY, Lytle BL, PollackCV Jr, Brindis RG et al. Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative. Arch Intern Med 2006;166:2027-34.
10. Lewis WR, Ellrodt AG, Peterson E, Hernandez AF, LaBresh KA, Cannon CP et al. Trends in the use of evidence-based treatments for coronary artery disease among women and the elderly. Circ Cardiovasc Qual Outcomes 2009;2:633-41.
11. Piccini JP, Hernandez AF, Zhao X, Patel MR, Lewis WR, Peterson ED et al. Quality of care for atrial fibrillation among patients hospitalized for heart failure. J Am Coll Cardiol 2009;54:1280-9.
12. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-12.
13. WyseDG,Waldo AL, DiMarco JP, Domanski MJ, RosenbergY, Schron EB et al. Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-33.
14. Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, GreenMet al. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med 2000;342:913-20.
15. Singh BN, Singh SN, Reda DJ, Tang XC, Lopez B, Harris CL et al. Amiodarone versus sotalol for atrial fibrillation. N Engl J Med 2005;352:1861-72.
16. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. The Sudden Cardiac Death in Heart Failure Trial I. Amiodarone or an implantable cardioverterdefibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.
17. Zimetbaum P. Amiodarone for atrial fibrillation. N Engl J Med 2007;356:935-41.
18. Wann LS, Curtis AB, January CT, Ellenbogen KA, Lowe JE, Estes NA III et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline). J Am Coll Cardiol 2011;57:223-42.
19. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for themanagement of atrial fibrillation. Europace 2012;14:1385-413.